153 related articles for article (PubMed ID: 18460034)
1. MDR1 genotypes do not influence the absorption of a single oral dose of 600 mg valacyclovir in healthy Chinese Han ethnic males.
Zhang Y; Jiang XH; Hu YQ; Li ZR; Su L; Wang ZG; Ma G
Br J Clin Pharmacol; 2008 Aug; 66(2):247-54. PubMed ID: 18460034
[TBL] [Abstract][Full Text] [Related]
2. MDR1 genotype do not influence the absorption of a single oral dose of 100 mg talinolol in healthy Chinese males.
Zhang WX; Chen GL; Zhang W; Tan ZR; Liu J; Zhou G; Hu DL; Zhou HH
Clin Chim Acta; 2005 Sep; 359(1-2):46-52. PubMed ID: 16170863
[TBL] [Abstract][Full Text] [Related]
3. Impact of MDR1 haplotypes derived from C1236T, G2677T/A and C3435T on the pharmacokinetics of single-dose oral digoxin in healthy Chinese volunteers.
Xu P; Jiang ZP; Zhang BK; Tu JY; Li HD
Pharmacology; 2008; 82(3):221-7. PubMed ID: 18810246
[TBL] [Abstract][Full Text] [Related]
4. Effect of multidrug resistance gene-1 (ABCB1) polymorphisms on the single-dose pharmacokinetics of cloxacillin in healthy adult Chinese men.
Yin OQ; Tomlinson B; Chow MS
Clin Ther; 2009 May; 31(5):999-1006. PubMed ID: 19539100
[TBL] [Abstract][Full Text] [Related]
5. A variant 2677A allele of the MDR1 gene affects fexofenadine disposition.
Yi SY; Hong KS; Lim HS; Chung JY; Oh DS; Kim JR; Jung HR; Cho JY; Yu KS; Jang IJ; Shin SG
Clin Pharmacol Ther; 2004 Nov; 76(5):418-27. PubMed ID: 15536457
[TBL] [Abstract][Full Text] [Related]
6. ABCB1 gene polymorphisms, ABCB1 haplotypes and ABCG2 c.421c > A are determinants of inter-subject variability in rosuvastatin pharmacokinetics.
Zhou Q; Ruan ZR; Yuan H; Xu DH; Zeng S
Pharmazie; 2013 Feb; 68(2):129-34. PubMed ID: 23469685
[TBL] [Abstract][Full Text] [Related]
7. CYP2C9*3(1075A>C), MDR1 G2677T/A and MDR1 C3435T are determinants of inter-subject variability in fluvastatin pharmacokinetics in healthy Chinese volunteers.
Zhou Q; Ruan ZR; Yuan H; Zeng S
Arzneimittelforschung; 2012 Nov; 62(11):519-24. PubMed ID: 22941809
[TBL] [Abstract][Full Text] [Related]
8. The Influence of MDR1 G2677T/a genetic polymorphisms on the pharmacokinetics of repaglinide in healthy Chinese volunteers.
Xiang Q; Cui YM; Zhao X; Yan L; Zhou Y
Pharmacology; 2012; 89(1-2):105-10. PubMed ID: 22398664
[TBL] [Abstract][Full Text] [Related]
9. Correlation between MDR1 methylation status in the promoter region and MDR1 genetic polymorphism in 194 healthy Chinese Han subjects.
Jiang ZP; Xu P; Liu RR; Li HD; Wang GP; Zhao XL; Chen FP
Pharmacogenomics; 2008 Dec; 9(12):1801-8. PubMed ID: 19072639
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and bioequivalence study of valacyclovir hydrochloride capsules after single dose administration in healthy Chinese male volunteers.
Lin H; Tian Y; Tian JX; Zhang ZJ; Mao GG
Arzneimittelforschung; 2010; 60(3):162-7. PubMed ID: 20422949
[TBL] [Abstract][Full Text] [Related]
11. Genetic polymorphisms in MDR1 and CYP3A5 and MDR1 haplotype in mainland Chinese Han, Uygur and Kazakh ethnic groups.
Li D; Zhang GL; Lou YQ; Li Q; Wang X; Bu XY
J Clin Pharm Ther; 2007 Feb; 32(1):89-95. PubMed ID: 17286792
[TBL] [Abstract][Full Text] [Related]
12. [Relationship between genetic polymorphism of multidrug resistance 1 gene and the risk of childhood acute lymphocytic leukemia].
Lü H; Du ZZ; Wang W; Wang W; Zhao WL; Wang Y; Hu SY; Chai YH
Zhonghua Er Ke Za Zhi; 2012 Sep; 50(9):692-6. PubMed ID: 23158821
[TBL] [Abstract][Full Text] [Related]
13. No effect of MDR1 C3435T polymorphism on oral pharmacokinetics of telmisartan in 19 healthy Chinese male subjects.
Guo X; Chen XP; Cheng ZN; Luo X; Guo R; Chen L; Chen J; Chen B; Peng J; Li YJ
Clin Chem Lab Med; 2009; 47(1):38-43. PubMed ID: 19072027
[TBL] [Abstract][Full Text] [Related]
14. Intra- and interindividual variabilities of valacyclovir oral bioavailability and effect of coadministration of an hPEPT1 inhibitor.
Phan DD; Chin-Hong P; Lin ET; Anderle P; Sadee W; Guglielmo BJ
Antimicrob Agents Chemother; 2003 Jul; 47(7):2351-3. PubMed ID: 12821497
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of acyclovir in the cat.
Owens JG; Nasisse MP; Tadepalli SM; Dorman DC
J Vet Pharmacol Ther; 1996 Dec; 19(6):488-90. PubMed ID: 8971679
[No Abstract] [Full Text] [Related]
16. Influence of ABCB1 gene polymorphisms on the pharmacokinetics of verapamil among healthy Chinese Han ethnic subjects.
Zhao LM; He XJ; Qiu F; Sun YX; Li-Ling J
Br J Clin Pharmacol; 2009 Sep; 68(3):395-401. PubMed ID: 19740397
[TBL] [Abstract][Full Text] [Related]
17. Bioequivalence studies of two different film-coated tablet formulations of valacyclovir of two different strengths in healthy volunteers.
Neves R; Almeida S; Filipe A; Spinola AC; Abolfathi Z; Lévesque A; Ortuño J; Torns A
Arzneimittelforschung; 2010; 60(5):273-81. PubMed ID: 20533765
[TBL] [Abstract][Full Text] [Related]
18. Influence of ABCB1 genetic polymorphisms on the pharmacokinetics of levosulpiride in healthy subjects.
Cho HY; Yoo HD; Lee YB
Neuroscience; 2010 Aug; 169(1):378-87. PubMed ID: 20438811
[TBL] [Abstract][Full Text] [Related]
19. CYP2C9*3(1075A > C), ABCB1 and SLCO1B1 genetic polymorphisms and gender are determinants of inter-subject variability in pitavastatin pharmacokinetics.
Zhou Q; Chen QX; Ruan ZR; Yuan H; Xu HM; Zeng S
Pharmazie; 2013 Mar; 68(3):187-94. PubMed ID: 23556337
[TBL] [Abstract][Full Text] [Related]
20. In Silico Absorption Analysis of Valacyclovir in Wildtype and Pept1 Knockout Mice Following Oral Dose Escalation.
Yang B; Smith DE
Pharm Res; 2017 Nov; 34(11):2349-2361. PubMed ID: 28770489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]